SCHEMBL4960976

SCHEMBL4960976

O=C1OC(c2ccc(O)cc2[N+](=O)[O-])(c2ccc(O)cc2[N+](=O)[O-])c2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
MEN1 O00255 5/20 0.63
KMT2A Q03164 5/20 0.63
LMNA P02545 5/20 0.63
TDP1 Q9NUW8 4/20 0.63
FTO Q9C0B1 3/20 0.63
GPR55 Q9Y2T6 2/20 0.63
RECQL P46063 2/20 0.63
BLM P54132 2/20 0.63
PRMT1 Q99873 2/20 0.63
ACE2 Q9BYF1 2/20 0.63
POLB P06746 2/20 0.63
NPSR1 Q6W5P4 2/20 0.63
CYP2C19 P33261 2/20 0.63
HTT P42858 2/20 0.63
ALOX12 P18054 1/20 0.63
HPGD P15428 1/20 0.63
SMAD3 P84022 1/20 0.63
SMN1; SMN2 Q16637 2/20 0.55
TP53 P04637 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9440019 0.82 MAPT (0.77) MAPTMEN1KMT2ALMNATDP1
Fluorescein SCHEMBL7740743 0.81 FTO (0.82) MAPTMEN1KMT2ALMNATDP1
Fluorescein SCHEMBL3180514 0.80 FTO (0.67) MAPTMEN1KMT2ALMNATDP1
Fluorescein SCHEMBL27917033 0.80 FTO (0.67) MAPTMEN1KMT2ALMNATDP1
SCHEMBL16285463 0.80 MAPT (0.73) MAPTMEN1KMT2ALMNATDP1
SCHEMBL4960577 0.78 MAPT (0.62) MAPTMEN1KMT2ALMNATDP1
SCHEMBL4201826 0.78 MAPT (0.59) MAPTMEN1KMT2ALMNATDP1
SCHEMBL4959116 0.77 LMNA (0.64) MAPTMEN1KMT2ALMNATDP1
Fluorescein SCHEMBL16533 0.77 FTO (1.00) MAPTMEN1KMT2ALMNATDP1
Fluorescein SCHEMBL30272223 0.77 FTO (1.00) MAPTMEN1KMT2ALMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871844-B1 BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2014-08-27 EP disclosed
EP-1871844-B1 BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2014-08-27 EP disclosed
EP-1871844-A2 NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C Technologies LLC (US) 2008-01-02 EP disclosed
WO-2007008389-A2 USE OF COLOR CHANGING INDICATORS IN CONSUMER PRODUCTS C2C TECHNOLOGIES LLC (US) 2007-01-18 WO disclosed
US-20070010400-A1 Use of color changing indicators in consumer products C2C TECHNOLOGIES, LLC 2007-01-11 US disclosed
US-20070010400-A1 Use of color changing indicators in consumer products C2C TECHNOLOGIES, LLC 2007-01-11 US disclosed
US-20070010400-A1 Use of color changing indicators in consumer products C2C TECHNOLOGIES, LLC 2007-01-11 US disclosed
US-20060257439-A1 Cleansing compositions with color changing indicator CRAYOLA LLC 2006-11-16 US disclosed
US-20060236470-A1 Novelty compositions with color changing indicator CRAYOLA LLC 2006-10-26 US disclosed
WO-2006105193-A2 PERSONAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105260-A1 ORAL CARE COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105261-A1 CLEANSING COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
WO-2006105191-A2 NOVELTY COMPOSITIONS WITH COLOR CHANGING INDICATOR C2C TECHNOLOGIES LLC (US) 2006-10-05 WO disclosed
US-20060222675-A1 Personal care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 US disclosed
US-20060222601-A1 Oral care compositions with color changing indicator C2C TECHNOLOGIES, LLC 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060222675-A1 Personal care compositions with color changing indicator CUTA, POLR1C, TYR MAPT 2485/4885MEN1 2817/4885KMT2A 3653/4885
US-20060257439-A1 Cleansing compositions with color changing indicator WASHC5, WASHC4, FHIT MAPT 3034/4885MEN1 1113/4885KMT2A 3047/4885
US-20060222601-A1 Oral care compositions with color changing indicator CA9, CA7, TAS2R7 MAPT 3664/4885MEN1 3449/4885KMT2A 2738/4885
US-20070010400-A1 Use of color changing indicators in consumer products NQO2, CA4, CA7 MAPT 3518/4885MEN1 3755/4885KMT2A 1465/4885
US-20060236470-A1 Novelty compositions with color changing indicator MITF, CRABP2, SHH MAPT 720/4885MEN1 3006/4885KMT2A 1508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.